Restoration of dysferlin expression in myogenic cells45 and blockade of innate immune activation46 reduce pathology in dysferlin-deficient mice, indicating that both the myofiber and inflammatory cell-specific deficits contribute to disease symptoms in dysferlinopathy. The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.